Dr. Noe R. Olvera, MD
Rheumatology (Rheumatology Physician)
2705 Hospital Dr, Suite 210
Victoria, TX 77901
Who else practices at this address →
Victoria County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Baylor College of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 523
Licensed in Texas since 2008, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: Baylor College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
TX license M8887 (first issued 2008; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Citizens Medical Center Victoria, TX
- De Tar Hospital Navarro Victoria, TX
- Cuero Regional Hospital Cuero, TX
- Memorial Hospital Gonzales, TX
- Yoakum Community Hospital Yoakum, TX
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 523
- Services billed
- 177,631
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 63,200 | 17 |
| Injection, tocilizumab, 1 mg | 41,280 | 13 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 22,750 | 36 |
| Injection, golimumab, 1 mg, for intravenous use | 15,450 | 17 |
| Established patient office or other outpatient visit, 20-29 minutes | 636 | 411 |
| Administration of chemotherapy into vein, 1 hour or less | 511 | 76 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 388 | 56 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 317 | 17 |
| Established patient office or other outpatient visit, 30-39 minutes | 297 | 187 |
| New patient office or other outpatient visit, 45-59 minutes | 83 | 83 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 53 payments worth $1,257 in total to this clinician.
| Amgen Inc. | $333 |
|---|---|
| Janssen Biotech, Inc. | $249 |
| Novartis Pharmaceuticals Corporation | $152 |
| AstraZeneca Pharmaceuticals LP | $109 |
| UCB, Inc. | $106 |
| Ani Pharmaceuticals, Inc. | $61.92 |
| Fresenius Kabi USA, LLC | $48.94 |
| GlaxoSmithKline, LLC. | $42.63 |
| Food and Beverage | $1,146 |
|---|---|
| Education | $111 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Sep 23, 2025 | Education TREMFYA · Immunology · in-kind | $59.99 |
| Amgen Inc. Aug 7, 2025 | Education UPLIZNA · Inflammation/Rare Disease · in-kind | $31.32 |
| Sobi, Inc Jul 9, 2025 | Education Kineret · Immunology · in-kind | $19.25 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.